URL has been copied successfully!
Dr. Vinay Prasad, head of the Food and Drug Administration‘s (FDA) Center for Biologics Evaluation and Research (CBER), which oversees vaccines and biotech drugs, is set to leave his position at the end of April, FDA Commissioner Marty Makary confirmed on Friday.
Prasad Exits FDA After Controversial Tenure
Prasad, who came to the FDA after leaving the University of California, San Francisco, had originally intended to remain at the agency for the full year of his leave from the university, Makary told The Wall Street Journal. His departure comes after the implementation of several new FDA policies, which were his primary focus.
Prasad’s division at the FDA is responsible for evaluating a wide …
Please follow us:
This post was originally published here
